Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Adv Exp Med Biol. 2020;1179:1-16. doi: 10.1007/978-981-13-9151-4_1.
Hepatitis B virus (HBV) is a DNA virus, belonging to the Hepadnaviridae family. It is a partially double-stranded DNA virus with a small viral genome (3.2 kb). Chronic HBV infection remains a global public health problem. If left untreated, chronic HBV infection can progress to end-stage liver disease, such as liver cirrhosis and hepatocellular carcinoma (HCC). In recent years, tremendous advances in the field of HBV basic and clinical research have been achieved, ranging from the HBV biological characteristics, immunopathogenesis, and animal models to the development of new therapeutic strategies and new drugs against HBV. In this overview, we begin with a brief history of HBV discovery and treatment milestones. We then briefly summarize the HBV research advances, which will be detailed in the following chapters.
乙型肝炎病毒(HBV)是一种 DNA 病毒,属于嗜肝 DNA 病毒科。它是一种部分双链 DNA 病毒,具有小的病毒基因组(3.2kb)。慢性 HBV 感染仍然是一个全球性的公共卫生问题。如果不治疗,慢性 HBV 感染可进展为终末期肝病,如肝硬化和肝细胞癌(HCC)。近年来,HBV 基础和临床研究领域取得了巨大进展,从 HBV 的生物学特性、免疫发病机制和动物模型到新的治疗策略和抗 HBV 的新药的发展。在这篇综述中,我们首先简要介绍 HBV 的发现和治疗里程碑。然后,我们简要总结了 HBV 的研究进展,以下各章将详细介绍。